In the BioHarmony Drug Report Database

"Preview" Icon

Candesartan cilexetil

Atacand (candesartan cilexetil) is a small molecule pharmaceutical. Candesartan cilexetil was first approved as Atacand on 1998-06-04. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. It is known to target type-1 angiotensin II receptor.

 

Trade Name

 

Atacand
 

Common Name

 

candesartan cilexetil
 

ChEMBL ID

 

CHEMBL1014
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Angiotensin II receptor antagonists

Image (chem structure or protein)

Candesartan cilexetil structure rendering